Paper Details

  1. Home
  2. Paper Details

Sensitive detection of quinoline-derivatized sitagliptin in small volumes of human plasma by MALDI-TOF mass spectrometry.

Author: LiYi-Shan, LuChi-Yu, TsengWei-Lung

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study developed a rapid and sensitive method for detecting the DPP-4 inhibitor sitagliptin in human plasma using MALDI-TOF MS. The method involves derivatization and microextraction, minimizing the use of organic solvents, with good sensitivity and accuracy.
Paper Details　
Original Abstract of the Article :
Dipeptidyl peptidase 4 (DPP-4) inhibitors are incretin-based medications used as oral antidiabetic agents for the treatment of type 2 diabetes. However, DPP-4 inhibitors produce side effects like acute pancreatitis, upper respiratory tract infection, nasopharyngitis, urinary tract infection, serious...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.talanta.2020.121143

データ提供：米国国立医学図書館（NLM）

Detecting Sitagliptin: A New Method for Monitoring Diabetes Treatment

This study ventures into the world of diabetes treatment, focusing on the detection of sitagliptin, a DPP-4 inhibitor. Imagine a vast desert where you're searching for a specific oasis, a tiny droplet in the sea of sand. This study tackles the challenge of detecting trace amounts of sitagliptin in human plasma, a critical factor in monitoring diabetes treatment. The researchers developed a novel method using derivatization-assisted microextraction, enhancing the sensitivity of detection through MALDI-TOF MS. This method significantly reduces the use of harmful chemicals and solvents, making it an environmentally friendly approach.

A Technological Leap in Diabetes Monitoring

This research introduces a promising new method for detecting sitagliptin, a DPP-4 inhibitor used to treat type 2 diabetes. The study's findings demonstrate the potential of derivatization-assisted microextraction combined with MALDI-TOF MS in monitoring diabetes treatment.

A Safer Approach to Diabetes Management

The eco-friendly nature of this method is a significant advantage. The study's findings highlight the importance of developing sustainable and environmentally friendly approaches to medical testing.

Dr.Camel's Conclusion

This study introduces a revolutionary approach to detecting sitagliptin in human plasma, a critical factor in monitoring diabetes treatment. The method is not only highly sensitive but also environmentally friendly, reducing the use of harmful chemicals. It's a significant step towards a greener and more efficient approach to diabetes management.

Date :
  1. Date Completed 2021-05-14
  2. Date Revised 2021-05-14
Further Info :

Pubmed ID

32797900

DOI: Digital Object Identifier

10.1016/j.talanta.2020.121143

Related Literature

Article Analysis
・Side Effects of sitagliptin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.